ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Liraglutide, Obesity, & PCOS "
Episode Synopsis
A recent well-designed American trial asked women with PCOS and obesity to take either placebo or GLP-1 agonist. 1/3 of participants were African-American and 2/3 were Caucasian. Most women had a goal of pregnancy.After 32 weeks, the women were compared for differences in weight loss, menses, and hormones. Links and study details can be found at www.yourfertilitypharmacist.comThe differences were significant in many ways.
More episodes of the podcast Your Fertility Pharmacist
Preconception Antibiotics and Fertility
12/01/2025
Accuracy & Mail-In Semen Kits
27/11/2024
Parenting after PGT
19/10/2024
PRP and POR
08/09/2024
Letrozole vs. Clomiphene: the OG Study
24/04/2024
COVID Infection after Embryo Transfer
10/02/2024
Liraglutide and Male Reproductive Health
30/09/2023
Use of a New Oral Drug in Egg Donor Cycles
12/07/2023
In God we trust